documents: FDA-2009-N-0665-0025
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2009-N-0665-0025 | FDA | FDA-2009-N-0665 | Ophthalmic and Topical Dosage Form New Animal Drugs; Change of Sponsor; Diclofenac; Ivermectin Otic Suspension - Final Rule | Rule | Final Rule | 2009-06-04T04:00:00Z | 2009 | 6 | 2009-06-04T04:00:00Z | 2014-01-08T13:44:43Z | E9-13015 | 0 | 0 | 09000064809c4ae9 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref